Publications by authors named "Robbert P Van Manen"

Claim this Profile
A
Artificial intelligence in pharmacovigilance signal management: a review of tools, implementations, research, and regulatory landscape.
Maria Antonietta Barbieri, Vera Battini, Carla Carnovale, Marianna Cocco, Despoina Georgia Papoutsi, Robbert P Van Manen

Expert Opin Drug Saf· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase.
Vera Battini, Robbert P Van Manen, Michele Gringeri, Giulia Mosini, Greta Guarnieri

Front Pharmacol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of anti-TNFα agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database.
Faizan Mazhar, Vera Battini, Michele Gringeri, Marco Pozzi, Giulia Mosini, Robbert P van Manen

Expert Opin Biol Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of the Food and Drug Administration Adverse Event Reporting System for Tramadol-Related Hypoglycemia.
Katherine M Juba, Robbert P van Manen, Shawn E Fellows

Ann Pharmacother· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signal detection for bleeding associated with the use of direct oral anticoagulants.
Kobi T Nathan, Kelly M Conn, Robbert P van Manen, Jack E Brown

Am J Health Syst Pharm· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dipeptidyl Peptidase-4 Inhibitor-Associated Pancreatic Carcinoma: A Review of the FAERS Database.
Angela K Nagel, Nabila Ahmed-Sarwar, Paul M Werner, Gabriela C Cipriano, Robbert P Van Manen

Ann Pharmacother· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How safe are recently FDA-approved antimicrobials? A review of the FDA adverse event reporting system database.
Tina M Khadem, Robbert P van Manen, Jack Brown

Pharmacotherapy· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential for linezolid-related blindness: a review of spontaneous adverse event reports.
Jack Brown, Samuel L Aitken, Robbert P van Manen

Pharmacotherapy· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signal detection methodologies to support effective safety management.
Robbert P van Manen, David Fram, William DuMouchel

Expert Opin Drug Saf· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis